Germany: Spillner succeeding Combé as Formycon CFO

Formycon, an independent developer of biosimilars, has appointed Enno Spillner as CFO effective April 1, 2023. Spillner has more than 23 years of experience in the biotechnology industry. In his latest position he was CFO of Evotec SE, an international science company for the discovery, development and production of highly effective medicines. At Evotec, he…

You must be a HMI Subscriber to view this content.

Subscribe Now »